NRx Pharmaceuticals and neurocare Group AG form partnership for neuroplastic drug treatment.

NRx Pharmaceuticals and neurocare Group AG are partnering to integrate neurocare clinics with HOPE Therapeutics clinics, leveraging 400+ Apollo® TMS machines nationwide. The program will combine TMS, neuroplastic drug treatment, hyperbaric oxygen, and psychotherapy to achieve remission from PTSD and Depression. The companies aim to offer an integrated treatment program to patients within driving distance of any American home by year-end 2026.